Zydus Lifesciences informed the exchange that it has entered into a Business Transfer Agreement to purchase the Active Pharmaceutical Ingredients (API) business of Watson Pharma for Rs 46.77 crore.
Watson Pharma reported a Turnover of Rs 750 crore in March 2021.
Zydus claims that thisacquisition will help the Company to expand its presence in the APIs space through increase in product pipeline and manufacturing capacity.
Source: BSE